FTC says pharma no to "Pharma Bro" Martin Shkreli
CBSN
The Federal Trade Commission on Friday said convicted fraudster Martin Shkreli should be held in contempt of court for launching a new drug company after he was banned from the pharmaceutical industry for life.
An earlier court order prohibited Shkreli "from directly or indirectly participating in any manner in the pharmaceutical industry" and ordered him to pay up to $65 million in monetary relief. Shkreli in 2018 was sentenced to seven years in prison for securities fraud. He served four years and was released from Pennsylvania's Allenwood Low Federal Correctional Institution in May of 2022.
The FTC asked the United District Court for the Southern District of New York to find Shkreli in civil contempt for failing to satisfy the monetary judgment and for forming a new company, called Druglike, described as "a platform for democratizing the access, costs and rewards of early-stage drug discovery."

The peace and tranquility of Muir Woods, just north of San Francisco – home to 500+ acres of old-growth redwoods – make it just about the last place you'd expect to find a fight brewing. "The fact that they're taking down whole groups of signs about climate change and our nation's history is disappointing, and embarrassing," said retired U.S. Park Ranger Lucy Scott In:

We share our planet with maybe 10 million species of plants, animals, birds, fish, fungi and bugs. And to help identify them, millions of people are using a free phone app. "Currently we have about six million people using the platform every month," said Scott Loarie, the executive director of iNaturalist, a nonprofit.

At ski resorts across the West this winter, viral images showed chairlifts idling over brown terrain in places normally renowned for their frosty appeal. Iconic mountain towns like Aspen, Colorado, and Park City, Utah, were seen with shockingly bare slopes, as the region endured a historic snow drought that experts warn could bring water shortages and wildfires in the months ahead. In:










